Synthego services

For CRISPR-based therapies, understanding the potential and actual off-target edits associated with your CRISPR drug components is critical to their safety and efficacy. Synthego has partnered with SeQure Dx, a leading off-target editing analysis company, to bring you best-in-class OTE analysis for your RUO-to-GMP gRNAs. Whether you are deciding among several gRNAs, characterizing your final gRNA, or filing your IND, we have the method that's right for you.